Disease Associations

Phase II Trial Initiated with Diffistat-G for Antibiotic-Associated Diarrhea

Published in AIDS Weekly, September 1st, 1997

GalaGen Inc., Arden Hills, Minnesota, announced that it has initiated a multi-center Phase II clinical trial of Diffistat-G, a polyclonal antibody drug for the treatment of antibiotic-associated diarrhea, a life-threatening illness caused by the pathogen, Clostridium difficile.

Principal investigators in the study include Ciaran Kelly, M.D., and J. Thomas LaMont, M.D., both of Beth Israel-Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.

Antibiotic-associated diarrhea is a major complication of broad spectrum antibiotic therapy, in which the normal bacterial flora in the colon are suppressed, permitting the bacterium...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1997-09-01)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry